Assessing an Oral EGFR Inhibitor,YK-209A in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR
Clinical trial NCT05767866 · UNKNOWN
Trial details
- NCT number
- NCT05767866
- Sponsor
- Suzhou Puhe Pharmaceutical Technology Co., LTD
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-30
- Primary completion
- 2023-12-30
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.